A window-of-opportunity clinical trial of dasatinib in women with newly diagnosed endometrial cancer

被引：0
|
作者：
Linda R. Duska
Gina R. Petroni
Heather Lothamer
William Faust
Jan H. Beumer
Susan M. Christner
Anne M. Mills
Paula M. Fracasso
Sarah J. Parsons
机构：
[1] University of Virginia School of Medicine,Department of Obstetrics and Gynecology, Division of Gynecology Oncology
[2] University of Virginia School of Medicine,Department of Microbiology, Immunology, and Cancer Biology
[3] University of Virginia School of Medicine,Department of Public Health Services
[4] UPMC Hillman Cancer Center,Cancer Therapeutics Program
[5] University of Pittsburgh School of Medicine,Division of Hematology
[6] University of Pittsburgh,Oncology, Department of Medicine
[7] University of Virginia School of Medicine,Department of Pharmaceutical Sciences, School of Pharmacy
[8] University of Virginia School of Medicine,Department of Pathology
[9] University of Virginia Cancer Center,Department of Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2019年 / 83卷
关键词：
Dasatinib; Endometrial cancer; Src inhibition; Pharmacodynamics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：473 / 482
页数：9
相关论文
共 50 条
  • [1] A window-of-opportunity clinical trial of dasatinib in women with newly diagnosed endometrial cancer
    Duska, Linda R.
    Petroni, Gina R.
    Lothamer, Heather
    Faust, William, Jr.
    Beumer, Jan H.
    Christner, Susan M.
    Mills, Anne M.
    Fracasso, Paula M.
    Parsons, Sarah J.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (03) : 473 - 482
  • [2] The effect of megestrol acetate 6 pterostilbene in endometrial cancer: A prospective, randomized, window-of-opportunity clinical trial
    Senguttuvan, Rosemary
    Frankel, Paul Henry
    Ruel, Nora
    Kebria, Mehdi
    Han, Ernest Soyoung
    Song, Mihae
    De Leon, Maria
    Invernizzi, Marta
    Eng, Melissa
    Tinsley, Raechelle
    Li, Aimin
    Schmolze, Daniel
    Chang, Sue
    Stella, Javier Arias
    Dellinger, Thanh Hue
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] ATTITUDES AND BARRIERS TO WINDOW-OF-OPPORTUNITY TRIALS IN WOMEN WHO HAVE UNDERGONE TREATMENT FOR ENDOMETRIAL CANCER
    Mandane, B.
    Moss, E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A349 - A349
  • [4] Prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer: A window of opportunity study
    Soliman, Pamela T.
    Zhang, Qian
    Broaddus, Russell R.
    Westin, Shannon N.
    Iglesias, David
    Munsell, Mark F.
    Schmandt, Rosemarie
    Yates, Melinda
    Ramondetta, Lois
    Lu, Karen H.
    GYNECOLOGIC ONCOLOGY, 2016, 143 (03) : 466 - 471
  • [5] WINDOW-OF-OPPORTUNITY CLINICAL TRIAL OF PEMBROLIZUMAB IN RECURRENT GLIOBLASTOMA PATIENTS
    de Groot, John
    Penas-Prado, Marta
    Mandel, Jacob
    O'Brien, Barbara
    Weathers, Shiao-Pei
    Loghin, Monica
    Kamiya-Matsuoka, Carlos
    Zhou, Shouhao
    Colen, Rivka
    Hunter, Kathy
    Fuller, Gregory
    Huse, Jason T.
    Rao, Ganesh
    Weinberg, Jeffrey
    Prabhu, Sujit
    Ferguson, Sherise
    Yuan, Ying
    Vence, Luis
    Allison, James
    Sharma, Padmanee
    Heimberger, Amy
    NEURO-ONCOLOGY, 2018, 20 : 2 - 2
  • [6] A phase 0 pharmacodynamic study of dasatinib in women with newly diagnosed endometrial cancer.
    Duska, Linda R.
    Lothamer, Heather
    Faust, William
    Petroni, Gina R.
    Fracasso, Paula M.
    Parsons, Sarah
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [7] Prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer: A window of opportunity study.
    Soliman, Pamela T.
    Broaddus, Russell
    Westin, Shannon Neville
    Iglesias, David A.
    Burzawa, Jennifer K.
    Zhang, Qian
    Munsell, Mark F.
    Schmandt, Rosemarie
    Ramondetta, Lois M.
    Lu, Karen H.
    Bae-Jump, Victoria Lin
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] A presurgical window-of-opportunity study of metformin in obesity-driven endometrial cancer
    Sivalingam, Vanitha
    McVey, Rhona
    Gilmour, Kyle
    Ali, Saad
    Roberts, Chris
    Renehan, Andrew
    Kitchener, Henry
    Crosbie, Emma
    LANCET, 2015, 385 : 90 - 90
  • [9] An olaparib window-of-opportunity trial in patients with early-stage endometrial carcinoma: POLEN study
    Romero, Ignacio
    Jesus Rubio, M.
    Medina, Manuel
    Matias-Guiu, Xavier
    Santacana, Maria
    Schoenenberger, Juan-Antonio
    Maria Guerra, Eva
    Cortes, Alfonso
    Minig, Lucas
    Coronado, Pluvio
    Fernando Cueva, Juan
    Gomez, Lourdes
    Malfettone, Andrea
    Sampayo, Miguel
    Llombart-Cussac, Antonio
    Poveda, Andres
    GYNECOLOGIC ONCOLOGY, 2020, 159 (03) : 721 - 731
  • [10] Window-of-opportunity clinical trial platform for evaluation of novel treatment strategies in renal cell cancer (WIRE).
    Sipple, Jamal A. N.
    Thomas, Martin G.
    Mossop, Helen
    Wason, James
    Gallagher, Ferdia
    Chhabra, Anita
    Warren, Anne
    Stone, John
    Venugopal, Balaji
    Oades, Grenville
    Welsh, Sarah Joanne
    Stewart, Grant D.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
12345